so it must be supplemented by and integrated with other sources for robust analysis and insight. For more information from the results of the Cegedim Strategic Data survey on pharma launch ...

Top Republican recipients of contributions from employees or PACS associated with the pharmaceutical/health products ...

The rise of counterfeit fentanyl-laced pharmaceuticals threatens public health. Innovative molecular analytical methods are ...

(NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced its annual performance analysis of ...

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS), a biopharmaceutical company with a market capitalization of $2.3 billion ...

Investors continue to flock to pharma services, targeting opportunities across the range of providers to the ...

Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Teva ...